止8月30日,据财新统计,在已经披露半年报的上市疫苗企业中,艾美疫苗、万泰生物、沃森生物、华兰生物、欧林生物等企业业绩均同比出现明显下滑。 国内疫苗可分为免疫规划苗和非免疫规划苗,即一类苗和二类苗。一
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 108.2 million
热评:
Hualan Biological Engineering,Inc. (华兰生物工程股份有限公司) (002007.SZ) reported a net profit of 562.1
Hualan Biological Engineering,Inc. (华兰生物工程股份有限公司) (002007.SZ) reported a net profit of 382.4
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 94 million yuan
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 519.6 million
Hualan Biological Engineering,Inc. (华兰生物工程股份有限公司) (002007.SZ) reported a net profit of 1.2 billion
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 504.7 million
Hualan Biological Engineering,Inc. (华兰生物工程股份有限公司) (002007.SZ) reported a net profit of 1.1 billion
图片
视频
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 108.2 million
热评:
Hualan Biological Engineering,Inc. (华兰生物工程股份有限公司) (002007.SZ) reported a net profit of 562.1
热评:
Hualan Biological Engineering,Inc. (华兰生物工程股份有限公司) (002007.SZ) reported a net profit of 382.4
热评:
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 94 million yuan
热评:
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 519.6 million
热评:
Hualan Biological Engineering,Inc. (华兰生物工程股份有限公司) (002007.SZ) reported a net profit of 1.2 billion
热评:
Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 504.7 million
热评:
Hualan Biological Engineering,Inc. (华兰生物工程股份有限公司) (002007.SZ) reported a net profit of 1.1 billion
热评: